The study also highlighted disparities in accurate diagnosis of myelodysplastic syndromes (MDS). Demographic and clinical disparities exist in the accurate diagnosis of older patients with ...
Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with AML transformed from MDS previously treated with azacitidine monotherapy.
Nearly 25 years after arriving at Fred Hutch Cancer Center for his hematology-oncology fellowship, Bart Scott, MD, has been named the Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair, ...
A review of recent research into myelodysplastic syndromes (MDS) shows a range of potential therapeutic targets. New research into the pathogenesis of myelodysplastic syndromes (MDS) may help aid the ...
Smokers with myelodysplastic syndromes (MDS) or a precursor condition had elevated levels of genetic mutations linked to the disease, a new study shows. The study also found that heavier smokers ...
FORT MYERS, Fla., Sept. 22, 2025 /PRNewswire/ -- Leveraging its proprietary real-world data, Florida Cancer Specialists & Research Institute, LLC (FCS) has concluded the first study to evaluate the ...
Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. In terms of future MDS research, a lot of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “It looks like, in the low-risk [myelodysplastic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback